This graphic tracks regulatory approvals for injectable cabotegravir and lenacapavir for PrEP as of October 2026. For additional details on product approvals, volumes, implementation, and price comparisons of long-acting PrEP, visit our dashboard on PrEPWatch.org.
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!